BioNano Genomics: Of The Current Report On Form 8k Filed By Bionano Genomics, Inc. (the “company”) With The Securities And Exchange Commission On June 13, 2025 (the “original Form 8k”) Solely To Correct An Error In The Reporting Of Broker Nonvotes On Proposal 3 And The Report Of Votes For And Broker Nonvotes On Proposal 4. Specifically, This Amendment No. 1 Amends The Original Form 8k To Reflect That There Were (i) 0 Broker Nonvotes Relating To Proposal 3 And 769,944 Broker Nonvotes Relating To Proposal 4 And (ii) A Total 396,176 Votes For Proposal 4 Instead Of The 369,176 Reported In The Original Form 8k. The Corrections Do Not Impact The Results Of The Votes On Either Proposal. No Other Changes Have Been Made To The Original Form 8k. Accordingly, This Amendment No. 1 Should Be Read In Conjunction With The Original Form 8k

Show full article

This functionality is available for registred users only

• Full name
  BioNano Genomics, Inc.
• Registration country
  USA
• Industry
  IT Services and Computer Programming
• М/S&P/F
  *** / *** / ***